Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Streptococci (Viridans group) |
0.008 |
0.015 |
0.004 - 0.03 |
ABT-492 |
3 |
Streptococci (Viridans group) |
0.008 |
0.06 |
≤0.008 - 1 |
Cethromycin (ABT-773) |
950 |
Streptococci (Viridans group) |
0.008 |
0.12 |
≤0.002 - 0.25 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
73 |
Streptococci (Viridans group) |
0.03 |
0.12 |
0.008 - >4 |
Retapamulin |
120 |
Streptococci (Viridans group) |
>0.03 |
>0.25 |
≤0.03 - >0.25 |
Clindamycin (Cleocin) |
73 |
Streptococci (Viridans group) |
0.03 |
0.25 |
≤0.03 - 1 |
Imipenem |
371 |
Streptococci (Viridans group) |
0.03 |
0.5 |
<0.03 - 4 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1060 |
Streptococci (Viridans group) |
>0.03 |
>1 |
≤0.015 - >1 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
73 |
Streptococci (Viridans group) |
0.03 |
1 |
≤0.015 - >32 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
371 |
Streptococci (Viridans group) |
0.06 |
0.06 |
0.015 - 0.12 |
Telavancin (TD-6424, Vibativ) |
73 |
Streptococci (Viridans group) |
0.06 |
0.12 |
0.002 - 2 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
950 |
Streptococci (Viridans group) |
0.06 |
0.25 |
? - ? |
Ceftobiprole (Zeftera) |
942 |
Streptococci (Viridans group) |
0.06 |
1 |
≤0.008 - 8 |
Cefditoren (Spectracef) |
119 |
Streptococci (Viridans group) |
0.06 |
2 |
≤0.06 - >2 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
73 |
Streptococci (Viridans group) |
0.06 |
2 |
≤0.06 - 32 |
Ceftriaxone (Rocephin) |
371 |
Streptococci (Viridans group) |
>0.06 |
>8 |
≤0.06 - >8 |
Clindamycin (Cleocin) |
265 |
Streptococci (Viridans group) |
0.064 |
1 |
? - ? |
Imipenem |
126 |
Streptococci (Viridans group) |
0.12 |
0.25 |
≤0.015 - 0.5 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
1396 |
Streptococci (Viridans group) |
0.12 |
0.25 |
0.03 - 1 |
Teicoplanin (Targocid) |
67 |
Streptococci (Viridans group) |
0.12 |
0.5 |
≤0.008 - 16 |
Ceftriaxone (Rocephin) |
412 |
Streptococci (Viridans group) |
0.12 |
0.5 |
≤0.12 - 0.5 |
SCH27899 |
129 |
Streptococci (Viridans group) |
0.12 |
0.5 |
≤0.12 - 4 |
Clindamycin (Cleocin) |
371 |
Streptococci (Viridans group) |
0.12 |
0.5 |
≤0.12 - 4 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
371 |
Streptococci (Viridans group) |
0.12 |
1 |
≤0.12 - >8 |
Cefepime (Maxipime) |
412 |
Streptococci (Viridans group) |
0.12 |
2 |
≤0.015 - 4 |
Ceftriaxone (Rocephin) |
73 |
Streptococci (Viridans group) |
0.12 |
2 |
≤0.12 - >4 |
Cefuroxime (Kefurox, Zinacef) |
73 |
Streptococci (Viridans group) |
0.12 |
4 |
0.06 - 4 |
Moxifloxacin (BAY 12-8039, Avelox) |
1060 |
Streptococci (Viridans group) |
>0.12 |
>8 |
≤0.06 - >8 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
265 |